欣母沛預(yù)防接受剖宮產(chǎn)術(shù)的妊高癥患者產(chǎn)后出血的效果及安全性
中圖分類號:R714.46+1文章編號:1006-1959(2025)12-0120-04
文獻標識碼:A
DOI:10.3969/j.issn.1006-1959.2025.12.025
Efficacyand SafetyofHemabate inPreventingPostpartumHemorrhage in Patients withPregnancy-inducedHypertensionUndergoing Cesarean Section
LAI Dongmei (Obstetricsand Gynecology Department of Yongxin County Maternal and Child Health Care Hospital, Yongxin ,Jiangxi,China)
Abstract:ObeiveTvestigateeectdfetyofmabateinpreventiostpaemoagipatitsithpregaucd hyprtensionuderggaeantiosFomeertvebratitsiauced underwentcesareastioiginoutyatealandCidHalCareHospialeletedstesubtsofissudyAode randomnumberablemetod,teyweredividedintocontrolgoupandstudygoupwith3Opatientsinchgoup.Thecontrolgrouastreated withoxytocindeudosteateditbatedeefingousd4ousaoa hemorhagerate)aglatiofction(ateletoutrotobictiatedartialtomboplastiiendeseactiodc gastrointestialootliaiooalloeadeoossulsotfd and4hoursfeeliveryinesudoupssstanthatinthotrolgoupndteateofostparemoageasloweraatn the control group( P? <0.05).Theplateletcountofthetwogroupswashigherthanthatbeforetreatment,theprothrombintimeandactivatedpartial thromboplastinewereshorterantoeeforetreamentiletelateletoutoftesudoupasgherthanatftooloupad theprothrombin timeand activatedpartial thromboplastin timewereshorter than thoseof thecontrol group( P <0.05).The incidence of adverse reactions in the study group was lower than that in the control group( P <0.05).Conclusion Hemabate is effective in preventing postpartum emoageiitsiaucdertedegaaiocholaiocio safety.It is worthy ofclinical application.
Key Words:Hemabate; Caesarean section; Pregnancy-induced hypertension; Postpartum hemorrhage;
剖宮產(chǎn)是產(chǎn)科常見手術(shù),在協(xié)助胎兒娩出方面具有重要意義,這種手術(shù)雖可幫助胎兒順利娩出,保障母嬰安全,但仍存在一定并發(fā)癥發(fā)生風(fēng)險,產(chǎn)后出血即為并發(fā)癥中常見的一種,其對產(chǎn)婦造成的危害較大,出血嚴重時可直接導(dǎo)致產(chǎn)婦死亡。(剩余5058字)
-
-
- 醫(yī)學(xué)信息
- 2025年12期
- 基于數(shù)據(jù)挖掘技術(shù)探討艾灸治療藥...
- 基于SMOTE算法的急性缺血性...
- 高危型HPV及TCT檢測聯(lián)合篩...
- 非酒精性脂肪性肝病基因組學(xué)研究...
- 基于知識圖譜相關(guān)研究的熱點及發(fā)...
- 基于文獻計量分析子宮內(nèi)膜容受性...
- 四川省縣級醫(yī)院急診科建設(shè)情況調(diào)...
- 基于使能評價的全院“一張床”管...
- 某三甲中醫(yī)醫(yī)院預(yù)約掛號成功率統(tǒng)...
- 中醫(yī)藥人用經(jīng)驗數(shù)據(jù)平臺建設(shè)與應(yīng)...
- 晚期血吸蟲病病例流行病學(xué)和臨床...
- 2022年鉛山縣常住居民死因監(jiān)...
- 中性粒細胞絕對值計數(shù)與血清白蛋...
- 黔西南地區(qū)非小細胞肺癌患者發(fā)病...
- 造血干細胞移植患者特征分布...
- 甘露醇、七葉皂苷鈉聯(lián)合應(yīng)用治療...
- 替格瑞洛與氯吡格雷對急性ST段...
- 新四聯(lián)治療心衰伴心臟擴大患者的...
- 宮頸擴張球囊聯(lián)合間苯三酚對瘢痕...
- 右美托咪定輔助腰-硬聯(lián)合麻醉在...
- 單上前牙即拔即種即刻修復(fù)和延期...
- 血栓彈力圖指導(dǎo)和大量輸血方案在...
- 平喘固本湯合補肺湯聯(lián)合頭孢他啶...
- COPD患者參與共享決策現(xiàn)狀調(diào)...
- 欣母沛預(yù)防接受剖宮產(chǎn)術(shù)的妊高癥...
- 小兒肺咳顆粒聯(lián)合注射用阿奇霉素...
- 丙泊酚復(fù)合瑞芬太尼靶控輸注麻醉...
- 鋼針內(nèi)固定在開放性指骨骨折患者...
- 阿卡波糖與達格列凈治療2型糖尿...
- 血清膽紅素、蛋白與尿酸檢測對冠...
- 解毒通腑湯加減治療對闌尾炎患者...
- 綜合護理干預(yù)對尿結(jié)石患者疾病認...
- 細節(jié)護理聯(lián)合綜合護理在泌尿外科...
- 醫(yī)護患共同決策護理對老年髖部骨...
- 綜合護理干預(yù)聯(lián)合提肛運動對痔瘡...
- 加速康復(fù)外科理念下精細化護理對...
- miRNA靶向Wnt/β-ca...
- 陳舊性下尺橈關(guān)節(jié)脫位治療研究進...
- 線粒體自噬在缺血性卒中的研究現(xiàn)...
- 玫瑰痤瘡發(fā)病機制及不同藥物治療...